ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 135 filers reported holding ZOGENIX INC in Q4 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,127,000 | -79.5% | 60,000 | -81.2% | 0.17% | -73.5% |
| Q2 2019 | $15,235,000 | +634.9% | 319,000 | +515.8% | 0.63% | +239.0% |
| Q1 2018 | $2,073,000 | -96.9% | 51,800 | -97.3% | 0.19% | -97.2% |
| Q3 2017 | $67,443,000 | +1950.6% | 1,924,200 | +746.5% | 6.64% | +1449.0% |
| Q2 2017 | $3,289,000 | -45.0% | 227,300 | -58.8% | 0.43% | -55.3% |
| Q1 2017 | $5,976,000 | +370.2% | 552,300 | +429.0% | 0.96% | +130.5% |
| Q4 2016 | $1,271,000 | – | 104,400 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 971,875 | $24,034,000 | 14.58% |
| Eversept Partners, LP | 2,013,467 | $49,793,039 | 12.38% |
| Pinz Capital Management, LP | 98,800 | $2,443,000 | 6.40% |
| RA Capital Management | 5,275,538 | $130,464,000 | 4.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,797 | $6,955,000 | 3.17% |
| Granite Point Capital Management, L.P. | 203,462 | $5,032,000 | 2.84% |
| Avoro Capital Advisors LLC | 2,800,000 | $69,244,000 | 2.34% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,029,699 | $25,464,000 | 2.33% |
| Eventide Asset Management | 2,841,300 | $70,265,000 | 2.28% |
| Perceptive Advisors | 3,452,921 | $85,390,000 | 2.22% |